106795-52-2 Suppliers

Recommended suppliersmore

106795-52-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 106795-52-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,7,9 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 106795-52:
(8*1)+(7*0)+(6*6)+(5*7)+(4*9)+(3*5)+(2*5)+(1*2)=142
142 % 10 = 2
So 106795-52-2 is a valid CAS Registry Number.

106795-52-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	1-(2-aminophenyl)cyclohexan-1-ol

1.2 Other means of identification

Product number	-
Other names	-

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:106795-52-2 SDS

106795-52-2Upstream product

106795-52-2Downstream Products

106795-52-2Relevant articles and documents

Borane-Catalyzed Synthesis of Quinolines Bearing Tetrasubstituted Stereocenters by Hydride Abstraction-Induced Electrocyclization

Maier, Alexander F. G.,Tussing, Sebastian,Zhu, Hui,Wicker, Garrit,Tzvetkova, Pavleta,Fl?rke, Ulrich,Daniliuc, Constantin G.,Grimme, Stefan,Paradies, Jan

supporting information, p. 16287 - 16291 (2018/10/15)

The borane-catalyzed synthesis of quinoline derivatives bearing tetrasubstituted stereocenters from vinyl anilines has been developed. Mechanistic studies and quantum-mechanical investigations support the hydride abstraction/electrocyclization/hydride add

POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS

-

Page/Page column 30, (2008/06/13)

The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of general Formula (I) wherein the groups R1, R2 and R3 may have the meanings indicated in the claims and in th

Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

-

Page/Page column 43, (2010/11/25)

Disclosed are medicament combinations which contain in addition to one or more, preferably one, compound of general formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″,

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 106795-52-2

CAS

106795-52-2